These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pertwee RG; Howlett AC; Abood ME; Alexander SP; Di Marzo V; Elphick MR; Greasley PJ; Hansen HS; Kunos G; Mackie K; Mechoulam R; Ross RA Pharmacol Rev; 2010 Dec; 62(4):588-631. PubMed ID: 21079038 [TBL] [Abstract][Full Text] [Related]
4. The neurobiology and evolution of cannabinoid signalling. Elphick MR; Egertová M Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563 [TBL] [Abstract][Full Text] [Related]
6. Role of lipids and lipid signaling in the development of cannabinoid tolerance. Martin BR Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. Onaivi ES Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083 [TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids and cannabinoid receptor genetics. Onaivi ES; Leonard CM; Ishiguro H; Zhang PW; Lin Z; Akinshola BE; Uhl GR Prog Neurobiol; 2002 Apr; 66(5):307-44. PubMed ID: 12015198 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling. Hiley CR; Ford WR Biol Rev Camb Philos Soc; 2004 Feb; 79(1):187-205. PubMed ID: 15005177 [TBL] [Abstract][Full Text] [Related]
11. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. Chiba T; Ueno S; Obara Y; Nakahata N J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165 [TBL] [Abstract][Full Text] [Related]
12. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview. Basavarajappa BS; Hungund BL Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043 [TBL] [Abstract][Full Text] [Related]
13. Basic neuroanatomy and neuropharmacology of cannabinoids. Breivogel CS; Sim-Selley LJ Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505 [TBL] [Abstract][Full Text] [Related]
14. Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation. Mastinu A; Premoli M; Ferrari-Toninelli G; Tambaro S; Maccarinelli G; Memo M; Bonini SA Horm Mol Biol Clin Investig; 2018 Mar; 36(2):. PubMed ID: 29601300 [TBL] [Abstract][Full Text] [Related]
17. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572 [TBL] [Abstract][Full Text] [Related]
18. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. De Petrocellis L; Di Marzo V J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654 [TBL] [Abstract][Full Text] [Related]
19. Molecular biology of cannabinoid receptors. Abood ME Handb Exp Pharmacol; 2005; (168):81-115. PubMed ID: 16596772 [TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids: new targets for drug development. Di Marzo ; Bisogno T; De Petrocellis L Curr Pharm Des; 2000 Sep; 6(13):1361-80. PubMed ID: 10903398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]